Quantcast

Leading European Universities Choose Elekta to Deliver Advanced 3D Brain Mapping Tool for Research

December 22, 2008

STOCKHOLM, Sweden, Dec. 22 /PRNewswire/ — Elekta Neuromag(R), the
world-leading equipment for non-invasive measurement of brain activity using
magnetoencephalography (MEG) technology has been ordered by the Moscow
Municipal University of Psychology and Education (Moscow, Russia) and the
University of Trento (Trento, Italy).

MEG is a powerful tool for studying normal brain function and brain
disorders. Elekta Neuromag is the world’s most advanced and most used MEG
system, providing real-time mapping of brain activity by non-invasively
measuring the magnetic fields produced by the brain. Electrical activity in
neurons in the brain produce magnetic fields that pass through brain tissue
and the skull, which can then be recorded outside the head using Elekta
Neuromag.

The first whole-head MEG in Russia, neuroscientists and those in related
fields at the Moscow Municipal University of Psychology and Education, plan to
use Elekta Neuromag for clinically oriented research applications, such as
autism in children. The University also plans to employ MEG technology for
cognitive neuroscience and neuropsychology research such as the study of human
emotion and brain abnormalities.

“We are extremely excited about our upcoming installation,” says Professor

Tatiana Stroganova, the Head of the Developmental Psychophysiology Department.
“We plan to use the MEG extensively to study temporal dynamics of cortical
networks underlying normal and aberrant brain organization of perception,
attention and emotion.”

Dedicated to brain and cognitive neuroscience research, a large group of
researchers at the University of Trento’s Center of Mind/Brain Sciences
(CIMeC) plan to use Elekta Neuromag to explore various fields of neuroscience
such as sensory processing, attention and action control, language, formation
of concepts and cognitive development.

The University of Trento has recruited physicians from Italy and elsewhere
in Europe, including Dr. Christoph Braun, former head of the MEG-Center at the
Eberhard Karls University Tubingen (Tubingen, Germany).

“The addition of Elekta Neuromag will complement already established
methods such as 4T functional magnetic resonance tomography (fMRT),
transcranial magnetic stimulation (TMS) as well as multi-channel EEG – thus
contributing to the advancement of our understanding of the brain,” says Dr.
Braun.

The University’s MEG-lab is situated in the Italian countryside. “Not only
is our MEG-lab optimally located for brain activity measurement, but patients
also have an opportunity to enjoy a beautiful view of the Alps,” continues
Braun.

“The acquisition of Elekta Neuromag by two prominent European Universities
is a major opportunity for Elekta to work with Europe’s top scientists in this
field,” says Stephen Otto, Chairman of Elekta’s Neuromag Business. “We look
forward to working with the Moscow Municipal University of Psychology and
Education and the University of Trento and hope the MEG systems will provide
valuable information to each of their respective programs.”

About Elekta

Elekta is a human care company pioneering significant innovations and
clinical solutions for treating cancer and brain disorders. The company
develops sophisticated state of the art tools and treatment planning systems
for radiation therapy and radiosurgery, as well as workflow enhancing software
systems across the spectrum of cancer care.

Stretching the boundaries of science and technology, providing intelligent
and resource-efficient solutions that offer confidence to both healthcare
providers and patients, Elekta aims to improve, prolong and even save patient
lives, making the future possible today.

Today, Elekta solutions in oncology and neurosurgery are used in over
5,000 hospitals globally, and every day more than 100,000 patients receive
diagnosis, treatment or follow-up with the help of a solution from the Elekta
Group. Elekta employs around 2,500 employees globally. The corporate
headquarter is located in Stockholm, Sweden, and the company is listed on the
Nordic Exchange under the ticker EKTAb. For more information about Elekta,
please visit www.elekta.com.

SOURCE Elekta


Source: newswire



comments powered by Disqus